WallStSmart
INSP

Inspire Medical Systems Inc

NYSE: INSP · HEALTHCARE · MEDICAL DEVICES

$53.41
-3.08% today

Updated 2026-04-29

Market cap
$1.54B
P/E ratio
10.92
P/S ratio
1.69x
EPS (TTM)
$4.89
Dividend yield
52W range
$48 – $163
Volume
1.0M

Inspire Medical Systems Inc (INSP) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$8.01M$16.43M$28.57M$50.59M$82.05M$115.38M$233.39M$407.86M$624.80M$802.80M$911.98M
Revenue growth (YoY)+105.0%+73.9%+77.1%+62.2%+40.6%+102.3%+74.7%+53.2%+28.5%+13.6%
Cost of revenue$2.81M$3.90M$6.02M$10.06M$13.64M$17.62M$33.28M$66.11M$96.58M$122.99M$133.22M
Gross profit$5.20M$12.52M$22.55M$40.54M$68.41M$97.76M$200.12M$341.74M$528.22M$679.82M$778.76M
Gross margin64.9%76.2%78.9%80.1%83.4%84.7%85.7%83.8%84.5%84.7%85.4%
R&D$7.08M$7.09M$6.19M$7.39M$12.84M$26.09M$37.35M$68.64M$116.54M$114.13M$103.17M
SG&A$2.63M$19.28M$3.81M$44.23M$72.47M$101.47M$154.81M$246.39M$422.69M$434.71M$624.64M
Operating income$-19.80M$-17.25M$-16.00M$-20.38M$-34.90M$-56.21M$-39.85M$-47.59M$-40.27M$36.08M$50.95M
Operating margin-247.1%-105.0%-56.0%-40.3%-42.5%-48.7%-17.1%-11.7%-6.4%4.5%5.6%
EBITDA$-19.65M$-17.12M$-15.47M$-18.13M$-30.59M$-54.13M$-38.62M$-40.73M$-40.27M$65.03M$64.91M
EBITDA margin-245.3%-104.2%-54.2%-35.8%-37.3%-46.9%-16.5%-10.0%-6.4%8.1%7.1%
EBIT$-19.77M$-17.23M$-15.76M$-18.52M$-31.08M$-54.97M$-39.84M$-42.59M$-40.27M$58.48M$50.95M
Interest expense$1.56M$1.30M$1.75M$3.30M$2.12M$2.12M$2.13M$1.68M$0.00$22000.00$137000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-21.34M$-18.53M$-17.51M$-21.83M$-33.24M$-57.20M$-42.04M$-44.88M$-21.15M$53.51M$145.42M
Net income growth (YoY)+13.2%+5.5%-24.7%-52.3%-72.1%+26.5%-6.8%+52.9%+353.0%+171.8%
Profit margin-266.3%-112.8%-61.3%-43.1%-40.5%-49.6%-18.0%-11.0%-3.4%6.7%15.9%